The development of rational strategies for selective immunotherapy against autoimmune demyelinating disease

Adv Immunol. 1991:49:357-79. doi: 10.1016/s0065-2776(08)60779-8.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Autoimmune Diseases / immunology
  • Autoimmune Diseases / therapy*
  • Cattle
  • Encephalomyelitis, Autoimmune, Experimental / immunology
  • Encephalomyelitis, Autoimmune, Experimental / therapy*
  • Epitopes / immunology
  • Gene Rearrangement, T-Lymphocyte
  • HLA-DR Antigens / immunology
  • Humans
  • Mice
  • Mice, Inbred Strains / genetics
  • Mice, Inbred Strains / immunology
  • Molecular Sequence Data
  • Multiple Sclerosis / genetics
  • Multiple Sclerosis / immunology
  • Multiple Sclerosis / therapy*
  • Myelin Basic Protein / genetics
  • Myelin Basic Protein / immunology*
  • Myelin Basic Protein / toxicity
  • Peptide Fragments / toxicity
  • Rats
  • Rats, Inbred Lew / genetics
  • Rats, Inbred Lew / immunology
  • Receptors, Antigen, T-Cell / genetics
  • Receptors, Antigen, T-Cell / immunology
  • Vaccination

Substances

  • Epitopes
  • HLA-DR Antigens
  • Myelin Basic Protein
  • Peptide Fragments
  • Receptors, Antigen, T-Cell